LONDON, Jan 20 (Reuters) - Britain's jobs market weakened in the run-up to November's budget announcement by finance minister Rachel Reeves and wage growth slowed, data showed on Tuesday, potentially ...

Security researchers from Radware have demonstrated techniques to exploit ChatGPT connections to third-party apps to turn indirect prompt injections into zero-click attacks with worm-like potential ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

NEW YORK, Dec 11 (Reuters) - After three consecutive interest rate cuts, investors now confront an uncertain U.S. monetary policy outlook for the year ahead, clouded by persistent inflation, data gaps ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Middle-income Americans are facing an economic hangover from the inflation of the last several years, and it has led to increased pessimism about their financial prospects, a new analysis finds. A ...

While the tech giants have plenty of money to build data centers, smaller outfits are taking on debt and taking big chances to work with them. By Cade Metz Cade Metz has covered artificial ...

The sting of rising prices continues to linger. Consumer price growth hit 3% in September on an annual basis, the Bureau of Labor Statistics reported Friday, slightly higher than the 2.9% rate seen in ...

As the U.S. military races to achieve true Joint All-Domain Command and Control (JADC2), the ability to move data seamlessly across dispersed forces has become as critical as the weapons they deploy.

Private payrolls plunged in September, complicating the picture for the US economy as policymakers and investors struggle to assess the state of the labor market amid a government shutdown. The Bureau ...

(RTTNews) - Valneva SE (VALN) announced positive four-year antibody persistence data following a single-dose vaccination with its chikungunya vaccine, IXCHIQ. The results demonstrate robust and ...